한글목차

유전자 검사 시장은 2025년에는 230억 4,000만 달러로 추정되고, 2032년에는 522억 2,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 연평균 성장률(CAGR)은 12.4%를 나타낼 전망입니다.

유전자 검사는 유전자, 염색체, 단백질의 변화를 확인하는 의료 검사의 일종입니다. 유전 검사의 결과는 의심되는 유전적 질환을 확인하거나 제외하거나 유전성 질환의 개발 또는 유전의 가능성을 판단하는데 도움이 됩니다.

시장 역학 :

유전성 질환 및 희귀질환 부담 증가, 종양학에서의 유전자 검사 적용 증가, 유전자 검사 용도 확대, 맞춤형 의료에 대한 높은 수요, 소비자 직접 유전자 검사에 대한 수요 증가는 예측 기간에 걸쳐 세계의 유전자 검사 시장 성장을 증가시킬 것으로 예상되는 주요 요인입니다.

예를 들어, 2022년 6월 유전체 진단 검사의 선두 주자인 Prenetics Group Limited는 대장암의 조기 징후를 감지하기 위한 새로운 비침습적 재택 스크리닝 검사인 ColloClear by Circle(ColoClear)을 발표했습니다.

게다가 2022년 3월에는 유전체 시퀀싱 그룹의 일루미나가 한 조직 샘플에서 폭넓은 종양 유전자를 검사하는 암 검사를 유럽에서 시작하여 희귀질환 환자와 치료법의 매칭에 도움이 되었습니다.

본 조사의 주요 특징

• 본 보고서는 세계의 유전자 검사 시장을 상세하게 분석하고 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모 및 복합연간 성장률(CAGR)을 제공합니다.
• 또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
• 엔터프라이즈 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 다음 매개변수를 기반으로 세계의 유전자 검사 시장 주요 기업 프로파일을 제공합니다.
• 이 보고서의 인사이트을 통해 마케팅 담당자와 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
• 세계의 유전자 검사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
• 이해관계자들은 세계의 유전자 검사 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의 및 범위
• 주요 요약
• 일관된 기회 맵(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 유전성 질환이나 희귀질환의 부담 증가
  • 유전자 검사의 고액의 비용
  • 유전자 검사의 응용 확대
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시/승인
• PEST 분석
• PORTER 분석
• 합병과 인수 시나리오

제4장 세계의 유전자 검사 시장 - 코로나 바이러스(COVID-19) 유행의 영향

• COVID-19 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 세계의 유전자 검사 시장, 유형별(2020-2032년)

• 보균자 검사
• 진단 검사
• 신생아 선별 검사
• 예측 및 전조 증상 검사
• 산전 검사
• 기타 유형

제6장 세계의 유전자 검사 시장, 질환별(2020-2032년)

• 알츠하이머병
• 암
• 낭포성 섬유증
• 겸상 적혈구 빈혈
• 듀센 근이영양증
• 지중해 빈혈
• 헌팅턴병
• 희귀 질환
• 기타 질환

제7장 세계의 유전자 검사 시장, 기술별(2020-2032년)

• 세포유전학 검사
• 생화학 검사
• 분자 검사

제8장 세계의 유전자 검사 시장, 지역별(2020-2032년)

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제9장 경쟁 구도

• 23&Me Inc.
• Qiagen NV
• Eurofins Scientific
• PerkinElmer Inc.
• Illumina Inc.
• Danaher Corporation
• Myriad Genetics Inc.
• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Quest Diagnostics Incorporated
• BioRad Laboratories Inc.
• DiaSorin SpA(Luminex Corporation)

제10장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Genetic Testing Market is estimated to be valued at USD 23.04 Bn in 2025 and is expected to reach USD 52.22 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.4% from 2025 to 2032.

Genetic testing is a type of medical test that identifies changes in genes, chromosomes, or proteins. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person's chance of developing or passing on a genetic disorder. Genetic testing is useful in many areas of medicine and can change the medical care people receives.

Market Dynamics:

Rise in burden of genetic and rare disorders, increasing application of genetic testing in oncology, growing applications of genetic testing, high demand for personalized medicine, and increasing demand for direct-to-consumer genetic testing are major factors expected to augment the growth of the global genetic testing market over the forecast period.

For instance, in June 2022, Prenetics Group Limited, one of the leaders in genomic and diagnostic testing, introduced a novel, non-invasive at-home screening test, ColoClear by Circle (ColoClear), for detecting early signs of colorectal cancer.

Moreover, in March 2022, Illumina, a genome sequencing group, launched a cancer test in Europe that checks for a wide range of tumor genes in one tissue sample, potentially helping patients with rare diseases to be matched up with treatment options.

Key features of the study:

• This report provides in-depth analysis of the global genetic testing market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global genetic testing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include 23&Me Inc., Qiagen NV, Eurofins Scientific, PerkinElmer Inc., Illumina Inc., Danaher Corporation, Myriad Genetics Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Quest Diagnostics Incorporated, BioRad Laboratories Inc., and DiaSorin S.p.A. (Luminex Corporation), among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global genetic testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genetic testing market.

Detailed Segmentation:

• Global Genetic Testing Market, By Type:
  • Carrier Testing
  • Diagnostic Testing
  • New-born Screening
  • Predictive and Presymptomatic Testing
  • Prenatal Testing
  • Other Types
• Global Genetic Testing Market, By Disease:
  • Alzheimer's Disease
  • Cancer
  • Cystic Fibrosis
  • Sickle Cell Anemia
  • Duchenne Muscular Dystrophy
  • Thalassemia
  • Huntington's Disease
  • Rare Diseases
  • Other Diseases
• Global Genetic Testing Market, By Technology:
  • Cytogenetic Testing
  • Biochemical Testing
  • Molecular Testing
• Global Genetic Testing Market, By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • 23&Me Inc.
  • Qiagen NV
  • Eurofins Scientific
  • PerkinElmer Inc.
  • Illumina Inc.
  • Danaher Corporation
  • Myriad Genetics Inc.
  • Abbott Laboratories
  • Hoffmann-La Roche Ltd.
  • Quest Diagnostics Incorporated
  • BioRad Laboratories Inc.
  • DiaSorin S.p.A. (Luminex Corporation)

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Disease
  • Market Snapshot, By Technology
  • Market Genetic Testing, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rise in burden of genetic/rare disorders
  • High cost of genetic testing
  • Growing applications of genetic testing
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Genetic Testing Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Genetic Testing Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Carrier Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diagnostic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• New-born Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Predictive and Presymptomatic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Prenatal Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Other Types
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Genetic Testing Market, By Disease, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Alzheimer's Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cystic Fibrosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Sickle Cell Anemia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Duchenne Muscular Dystrophy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Thalassemia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Huntington's Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Rare Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Other Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Genetic Testing Market, By Technology, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cytogenetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Biochemical Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Molecular Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Genetic Testing Market, By Geography, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)

9. Competitive Landscape

• 23&Me Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Qiagen NV
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Eurofins Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• PerkinElmer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Illumina Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Myriad Genetics Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F. Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Quest Diagnostics Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BioRad Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DiaSorin S.p.A. (Luminex Corporation)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us